Rohto Pharmaceutical Co.,Ltd. (TYO:4527)
2,114.50
-5.50 (-0.26%)
Jul 29, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Skin Care | 176.82B | Log In | Log In | Log In | Log In | Upgrade |
Skin Care Growth | 12.87% | Log In | Log In | Log In | Log In | Upgrade |
Eye Care | 53.40B | Log In | Log In | Log In | Log In | Upgrade |
Eye Care Growth | 10.84% | Log In | Log In | Log In | Log In | Upgrade |
Oral Medication | 30.90B | Log In | Log In | Log In | Log In | Upgrade |
Oral Medication Growth | 16.21% | Log In | Log In | Log In | Log In | Upgrade |
Other | 9.72B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 34.34% | Log In | Log In | Log In | Log In | Upgrade |
Other | 9.72B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 34.34% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Other | 2.79B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 19.21% | Log In | Log In | Log In | Log In | Upgrade |
Japan | 156.85B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | 14.77% | Log In | Log In | Log In | Log In | Upgrade |
Asia | 78.75B | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | 11.27% | Log In | Log In | Log In | Log In | Upgrade |
America | 18.57B | Log In | Log In | Log In | Log In | Upgrade |
America Growth | 11.47% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 13.88B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 13.51% | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.79B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 19.21% | Log In | Log In | Log In | Log In | Upgrade |